Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 2 publications
Exceptional responders with invasive mucinous adenocarcinomas: a phase 2 trial of bortezomib in patients with KRAS G12D-mutant lung cancers.
Journal: Cold Spring Harbor molecular case studies
Published: November 12, 2018
Stage IV lung carcinoids: spectrum and evolution of proliferation rate, focusing on variants with elevated proliferation indices.
Journal: Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc
Published: September 29, 2018
Showing 1-2 of 2
Last Updated: 09/26/2026